The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Therapeutic Approaches for Peripheral and Central Neuropathic Pain
Open accessAbstract
Neuropathic pain is a chronic secondary pain condition, which is a consequence of peripheral or central nervous (somatosensory) system lesions or diseases. It is a devastating condition, which affects around 7% of the general population. Numerous etiological factors contribute to the development of chronic neuropathic pain. It can originate from the peripheral part of the nervous system such as in the case of trigeminal or postherpetic neuralgia, peripheral nerve injury, painful polyneuropathies, or radiculopathies. Central chronic neuropathic pain can develop as a result of spinal cord or brain injury, stroke, or multiple sclerosis. As first-line pharmacological treatment options, tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, and gabapentinoids are recommended. In trigeminal neuralgia, carbamazepine and oxcarbazepine are the first-choice drugs. In drug-refractory cases, interventional, physical, and psychological therapies are available. This review was structured based on a PubMed search of papers published in the field from 2010 until May 2019.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980 · cited 8×
“From the wide group of antiepileptics, gabapentinoids, such as gabapentin/gabapentin ER/enacarbil (12003600mg/day tid) and pregabalin (300-600mg/day bid), are the first-choice drugs in the treatment of all types of NP with strong recommendation based on high quality of evidence [2, 12, 13, 36, 74].”
BackgroundMethodInfluentialTreede, R.-D., Rief, W., Barke, A., Aziz, Q., Bennett, M. I., Benoliel, R., Cohen, M., Evers, S., Finnerup, N. B., First, M. B., et al. (2019) · Pain · doi:10.1097/j.pain.0000000000001384 · Cited by 3,478
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873 · cited 17×
“, tetrahydrocannabinol (THC)/cannabidiol (CBD) oromucosal spray) in chronic central NP associated with MS might be beneficial, but generally, it is still a controversial issue due to their inconsistent results regarding their efficacy and numerous side effects [2, 12, 70, 71].”
BackgroundInfluentialPsychological therapies for the management of chronic pain (excluding headache) in adults
Williams, A. C. D. C., Eccleston, C., & Morley, S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007407.pub3 · Cited by 1,634
The IASP classification of chronic pain for ICD-11: chronic postsurgical or posttraumatic pain
Schug, S. A., Lavand'homme, P., Barke, A., Korwisi, B., Rief, W., Treede, R.-D., & Pain, T. I. T. F. T. C. O. C. (2019) · Pain · doi:10.1097/j.pain.0000000000001413 · Cited by 841
Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia
Lunn, M. P., Hughes, R. A., & Wiffen, P. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007115.pub3 · Cited by 565 · cited 11×
“The recommendation of CBT in PDP and NP associated with cancer or HIV patients was graded as a good practice point (GPP) [101].”
BackgroundInfluentialGabapentin for chronic neuropathic pain in adults
Wiffen, P. J., Derry, S., Bell, R. F., Rice, A. S., Tölle, T. R., Phillips, T., & Moore, R. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub4 · Cited by 561
Moulin, D., Boulanger, A., Clark, A., Clarke, H., Dao, T., Finley, G., Furlan, A., Gilron, I., Gordon, A., Morley-Forster, P., et al. (2014) · Pain Research and Management · doi:10.1155/2014/754693 · Cited by 529
Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy
Iqbal, Z., Azmi, S., Yadav, R., Ferdousi, M., Kumar, M., Cuthbertson, D. J., Lim, J., Malik, R. A., & Alam, U. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.04.001 · Cited by 487 · cited 1×
“The first-line drugs in PDP as recommended by different international therapeutic guidelines are the following: duloxetine, gabapentin, pregabalin, TCAs (amitriptyline), and venlafaxine ER (extended release) [12, 39, 40].”
BackgroundPsychological therapies (Internet-delivered) for the management of chronic pain in adults
Eccleston, C., Fisher, E., Craig, L., Duggan, G. B., Rosser, B. A., & Keogh, E. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010152.pub2 · Cited by 271 · cited 2×
“Internet-delivered psychological therapies Nonheadache chronic pain Similar effect to that of conventional faceto-face psychological intervention [97]”
BackgroundMethod
Cited by
Peripheral Nerve Injury Treatments and Advances: One Health Perspective
Lopes, B., Sousa, P., Alvites, R., Branquinho, M., Sousa, A. C., Mendonça, C., Atayde, L. M., Luís, A. L., Varejão, A. S. P., & Maurício, A. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020918 · Cited by 381
“Neuropathic pain is one of the most complicated pain syndromes to regulate and can cause this kind of disorder can cause devastating impacts on patients’ daily routines and impair their emotional well-being [6, 7].”
BackgroundEfficacy of biofeedback in rehabilitation of musculoskeletal disorders: a systematic review
de la Barra Ortiz, H. A., Matamala, A. M., Inostroza, F. L., Araya, C. L., & Mondaca, V. N. (2022) · Advances in Rehabilitation · doi:10.5114/areh.2022.113241 · Cited by 6
Metadata
- Authors
- Szok, D., Tajti, J., Nyári, A., Vécsei, L., & Trojano, L.
- Venue
- Behavioural Neurology
- Publisher
- Wiley
- Published
- 2019-11-21
- Volume
- 2019
- Pages
- 1-13
- ISSN
- 0953-4180 (ISSN-L)
- 1875-8584
- OpenAlex
- W2989863152
- Cited by
- 217
- References
- 18
- FWCI
- 10.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Therapeutic Approaches for Peripheral and Central Neuropathic Pain. https://app.cochat.ai/papers/10.1155/2019/8685954
- The paper
- Szok, D., Tajti, J., Nyári, A., Vécsei, L., & Trojano, L. (2019). Therapeutic Approaches for Peripheral and Central Neuropathic Pain. Behavioural Neurology. https://doi.org/10.1155/2019/8685954
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.